Hence, we examined mTOG abundance as a direct readout of PUS7 activity in primary HSPCs from 50 patients representing the spectrum of MDS subgroups, including chronic myelomonocytic leukaemia and MDS-derived sAML, with clinical follow-up (Supplementary Table 3). This evidence concerns the gene PUS7 and myelodysplastic syndrome.